Literature DB >> 35529772

Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines.

Francesco Drago1, Giulia Ciccarese1, Aurora Parodi1,2.   

Abstract

Entities:  

Year:  2022        PMID： 35529772      PMCID： PMC9061133          DOI： 10.1016/j.jdin.2022.03.018

Source DB:  PubMed          Journal:  JAAD Int        ISSN： 2666-3287


× No keyword cloud information.
  5 in total

1.  Distinguishing the status of human herpesvirus 6 and 7 infection.

Authors:  Francesco Drago; Giulia Ciccarese; Alfredo Rebora
Journal:  Int J Dermatol       Date:  2015-07-23       Impact factor: 2.736

Review 2.  Pityriasis Rosea: A Comprehensive Classification.

Authors:  Francesco Drago; Giulia Ciccarese; Alfredo Rebora; Francesco Broccolo; Aurora Parodi
Journal:  Dermatology       Date:  2016-04-21       Impact factor: 5.366

3.  Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.

Authors:  Jordan E Buckley; Laura N Landis; Ronald P Rapini
Journal:  JAAD Int       Date:  2022-02-09

4.  Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.

Authors:  Francesco Drago; Francesco Broccolo; Giulia Ciccarese
Journal:  Clin Dermatol       Date:  2022-01-31       Impact factor: 3.541

5.  Human herpesvirus-6, -7, and Epstein-Barr virus reactivation in pityriasis rosea during COVID-19.

Authors:  Francesco Drago; Giulia Ciccarese; Alfredo Rebora; Aurora Parodi
Journal:  J Med Virol       Date:  2020-10-07       Impact factor: 20.693
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.